ArticleScientific reports2025
Machine learning prognosis model for locally recurrent rectal cancer patients after radioactive
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
To develop and validate a multiscale radiomics prognostic tool for accurately predicting local control (LC) and overall survival (OS) in locally recurrent rectal cancer (LRRC) patients underwent CT-guided radioactive 125I seed implantation (RISI). 189 LRRC patients who treated with RISI were eligible for exploratory retrospective study and randomly divided into training and validation sets. Intra-and peri-tumoral handcrafted radiomics features (RFs) selection was performed using the univariate analysis and LASSO-Cox model. The deep learning RFs were also performed same procedures. The random survival forest (RSF) and Cox hazard regression (CHR) prognostic models were fitted with bootstrapping resampling and comprehensively evaluated by the concordance index (C-index), integrated brier score (IBS), and time-dependent area under the curve (tAUC). Among all peritumoral radscores (RS), the RSperi1mm and RSperi4mm demonstrated the best prediction for LC for OS in the validation set, respectively. The addition of deep learning radscores can also improve prediction efficiency. The combined RSF model demonstrated robust performance compared to CHR model for LC prediction, achieving a C-index (95%CI) of 0.78 (0.74–0.84) and an IBS of 0.13 (0.12–0.14). Similar results were observed in predicting OS with a C-index of 0.76 (0.75–0.77), an IBS of 0.11 (0.10–0.12). According to the RSF model predictions, the LRRC patients were significantly dichotomized into two different prognostic groups (p < 0.001). The RSF model could provide more accurate LC and OS prediction and remarkable prognostic stratification than the CHR model for LRRC patients after RISI treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.